BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC
· Real-Time Price · USD
5.27
-0.09 (-1.68%)
At close: Aug 15, 2025, 2:49 PM
BioNexus Gene Lab Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.6M | 4.38M | 4.14M | 5.41M | 5.83M | 5.93M | 6.15M | 1.76M | 1.97M | 2.12M | 1.46M | 1.34M | 1.84M | 2.12M | 1.7M | 1.48M | 2.47M |
Short-Term Investments | n/a | n/a | n/a | 3.21M | 3.34M | 3.31M | 1.44M | 1.46M | n/a | 1.51M | 984.09K | 849.74K | 1.24M | 1.55M | 1.03M | 1.06M | 1.62M |
Long-Term Investments | 1.21M | 1.27M | 1.99M | 1.71M | 1.66M | 1.7M | 1.55M | 1.23M | 1.19M | 1.15M | 923.98K | 1.04M | 909.63K | 749.03K | 670.78K | 614.72K | 571.61K |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.67M | n/a | -2.72M | -2.39M | -2.6M | n/a | n/a | n/a | n/a | -2 |
Receivables | 1.77M | 1.58M | 1.43M | 987.96K | 839.56K | 857.26K | 1.02M | 2.25M | 2.59M | 2.9M | 2.78M | 2.83M | 3.04M | 3.36M | 4.19M | 3.88M | 3.6M |
Inventory | 1.18M | 1.39M | 1.39M | 1.03M | 1.08M | 1.14M | 1.11M | 1.17M | 899.64K | 977.81K | 1.1M | 1.51M | 1.65M | 1.52M | 1.49M | 1.7M | 1.47M |
Other Current Assets | n/a | 203.66K | 87.81K | 407.87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 147.12K | 23.43K | n/a | n/a |
Total Current Assets | 6.54M | 7.43M | 7.04M | 7.84M | 7.91M | 8.05M | 8.27M | 5.23M | 5.46M | 6.02M | 5.41M | 5.77M | 6.6M | 7.15M | 7.4M | 7.1M | 7.56M |
Property-Plant & Equipment | 1.72M | 1.74M | 1.96M | 1.59M | 1.6M | 1.65M | 1.64M | 1.44M | 1.53M | 1.57M | 1.47M | 1.56M | 1.66M | 1.68M | 1.69M | 1.73M | 1.76M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.94M | 3M | 3.96M | 3.3M | 3.26M | 3.35M | 3.2M | 2.67M | 2.73M | 2.72M | 2.39M | 2.6M | 2.57M | 2.42M | 2.36M | 2.35M | 2.34M |
Total Assets | 9.48M | 10.43M | 11M | 11.14M | 11.16M | 11.4M | 11.47M | 7.9M | 8.19M | 8.74M | 7.8M | 8.37M | 9.18M | 9.57M | 9.77M | 9.45M | 9.9M |
Account Payables | 1.18M | 1.5M | 1.03M | 954.78K | 1.43M | 1.4M | 1.57M | 1.82M | 1.49M | 1.86M | 1.28M | 1.42M | 1.83M | 2.01M | 2.41M | 2.39M | 2.93M |
Deferred Revenue | 21.96K | 95.88K | 22.83K | 5.94K | n/a | n/a | 8.22K | 7.09K | 15.32K | 23.12K | 8.5K | n/a | 107.00 | 107.58K | 148.2K | 106.16K | 28.87K |
Short-Term Debt | n/a | 50.82K | n/a | 53.21K | n/a | n/a | 33.9K | 16.1K | n/a | n/a | 11.78K | 14.03K | 37.44K | n/a | 39.46K | n/a | 39.64K |
Other Current Liabilities | n/a | 301.28K | 48.21K | 175.82K | 254.86K | 194.11K | -1.94K | 14.67K | n/a | 103.37K | 24.16K | 58.26K | 75.42K | 71.81K | 26.28K | 141.13K | 27.51K |
Total Current Liabilities | 1.56M | 1.95M | 1.41M | 1.4M | 1.72M | 1.63M | 1.64M | 1.88M | 1.56M | 2M | 1.33M | 1.5M | 1.98M | 2.33M | 2.66M | 2.58M | 3.04M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 147.94K | 159.74K | 192.01K | 194.62K | 100.76K | 111.02K | 133.75K | 58.7K | 66.35K | 71.07K | 39.66K | 44.54K | 62.65K | 65.86K | 48.58K | 59.11K | 70.67K |
Total Liabilities | 1.71M | 2.11M | 1.61M | 1.59M | 1.82M | 1.74M | 1.78M | 1.94M | 1.63M | 2.08M | 1.37M | 1.55M | 2.05M | 2.39M | 2.71M | 2.63M | 3.11M |
Total Debt | 200.11K | 210.56K | 226.58K | 235.91K | 121.35K | 133.4K | 138.76K | 45.76K | 52.41K | 56.77K | 25.9K | 31.73K | 71.95K | 76.95K | 86.24K | 97.15K | 108.5K |
Common Stock | 17.33M | 17.33M | 17.33M | 17.19M | 17.19M | 17.19M | 17.28M | 10.93M | 10.93M | 10.93M | 10.93M | 10.93M | 10.78M | 10.78M | 10.78M | 10.78M | 10.78M |
Retained Earnings | -4.07M | -3.44M | -3.09M | -1.75M | -1.95M | -1.84M | -1.78M | 828.08K | 1.09M | 1.16M | 1.31M | 1.39M | 1.53M | 1.51M | 1.42M | 1.13M | 1.1M |
Comprehensive Income | -482.84K | -555K | -4.85M | -884.74K | -887.2K | -677.29K | -800.6K | -781.99K | -448.1K | -409.06K | -807.39K | -486.8K | -169.04K | -100.26K | -139.19K | -82.25K | -74.78K |
Shareholders Equity | 7.77M | 8.32M | 9.39M | 9.55M | 9.34M | 9.66M | 9.69M | 5.96M | 6.56M | 6.67M | 6.42M | 6.82M | 7.13M | 7.18M | 7.05M | 6.81M | 6.79M |
Total Investments | 1.21M | 1.27M | 1.99M | 1.71M | 1.66M | 1.7M | 1.55M | 1.23M | 1.19M | 1.15M | 923.98K | 1.04M | 909.63K | 749.03K | 670.78K | 614.72K | 571.61K |